Strykr Analysis
BullishStrykr Pulse 71/100. Breadth improvement, sector rotation, and technicals favor small caps and healthcare. Threat Level 2/5.
If you’ve spent the past two years glued to the AI hype cycle and mega-cap tech’s relentless moonshot, you might want to blink and check your P&L. The S&P 500’s heavy hitters are suddenly looking hungover, and the rotation that’s been whispered about for months is now blaring like a fire alarm. This isn’t just a blip, there’s a tectonic shift underway, and the numbers don’t lie.
Let’s start with the plain facts. The so-called “Mag 7” (yes, we’re all tired of the nickname, but the weightings are still obscene) have been dragging the S&P 500 lower this month, according to Seeking Alpha’s latest market wrap. Small and microcaps are outperforming, healthcare is attracting fresh capital, and REITs are quietly crawling out of their graves. The S&P 500’s top-heavy structure, where seven stocks command roughly 34% of the index, has left it exposed to the kind of rotation that can turn a gentle correction into a full-blown regime change. This isn’t just sector rotation, it’s a re-rating of risk across the board.
The numbers are stark. The S&P 500’s mega-cap cohort is down sharply in June, while the Russell 2000 and S&P 600 microcaps have posted their best relative performance in over a year. Healthcare ETFs have seen inflows for three consecutive weeks, and REITs, left for dead during the Fed’s hiking cycle, are now seeing their first signs of life as rate cut bets resurface. The Wall Street Journal’s latest AI chipmaker coverage makes it clear: the cash is flowing out of the usual suspects and into the hands of memory chip makers, healthcare, and real asset plays. The “AI trade” is no longer a monolith. It’s fragmenting, and the market is finally starting to care about valuation again.
What’s driving this? Start with the obvious: the Fed pivot is no longer a matter of “if” but “when.” Kevin Warsh’s new regime at the Federal Reserve is already being dissected for clues, but the market’s collective yawn at the latest Fed minutes tells you everything. The real story is that inflation is cooling, the labor market is softening, and investors are finally willing to look beyond the usual suspects for growth. Abby Joseph Cohen’s warning about stock valuations should be ringing in everyone’s ears, lofty prices are hiding real risks, especially in the names that have been carrying the index for years.
But this isn’t just about macro. The technicals are screaming rotation. Weekly charts show the Mag 7 breaking down relative to the broader market, with percent-of-stocks-above-50-day moving averages rolling over. The S&P 500’s breadth is improving even as the index itself stagnates. This is the kind of divergence that used to get you laughed out of the room in 2021, but now it’s the only game in town.
The cross-asset picture matters, too. Commodities are flatlining (DBC at $28.55, unchanged), and tech ETFs like XLK are stuck in neutral at $184.83. The real action is happening under the surface, where healthcare and REITs are quietly outperforming. Bond markets are sending mixed signals, but the consensus is clear: the era of easy mega-cap dominance is over, at least for now.
So what’s the trade? This is where it gets interesting. If you’re still overweight the Mag 7, you’re effectively running a crowded carry trade with no upside catalyst. The risk-reward has flipped. Meanwhile, small caps, healthcare, and REITs offer asymmetric upside if the rotation has legs. The technicals back this up: relative strength in the Russell 2000, improving breadth, and sector flows all point to further outperformance.
Strykr Watch
Keep your eyes glued to the Russell 2000’s 2,000 level, if it holds, the rotation narrative gets another shot of adrenaline. For healthcare, XLV’s 50-day moving average is the line in the sand. REITs (VNQ) need to clear their 200-day for confirmation. On the flip side, watch for the Mag 7’s relative strength index (RSI) to dip below 40, that’s a signal the unwind isn’t done. Breadth indicators like percent-of-stocks-above-50-day are your early warning system. If they keep rising while the index flatlines, the rotation is real.
Risks? Plenty. If the Fed surprises hawkish, or if inflation data re-accelerates, the risk-on trade could get torched. A sharp correction in small caps would unwind the rotation in a heartbeat. But the opportunity is clear: this is the first time in years that the market is rewarding diversification over concentration. The days of hiding in the Mag 7 are over.
For traders, the setup is actionable. Long small caps on dips, with stops just below key support. Healthcare and REITs offer tactical long entries if momentum holds. If you’re still long mega-cap tech, consider trimming, there’s more downside risk than upside here. The rotation is real, and it’s just getting started.
Strykr Take
This isn’t your 2023 market. The rotation away from mega-cap tech is more than a headline, it’s the start of a new regime. Ignore it at your own risk. The smart money is already moving. Don’t be the last one out of the Mag 7 party.
Sources (5)
A Month For 'The Rest'
We've made numerous mentions of the weakness in mega-cap stocks so far this month, and given their weightings in the S&P 500, the impact on the index
Chip Makers Are Profiting Off AI at the Expense of Just About Everyone Else
We are witnessing an extraordinary transfer of cash from the providers of AI—and, perhaps one day, AI users—to memory-chip makers.
Here is how Alan Greenspan ran the Fed—and how Kevin Warsh's approach compares
The approach of the new Federal Reserve head might not always align with the standard his predecessor set.
Tanker struck in Strait of Hormuz as U.S.-Iran tensions escalate
A tanker in the Strait of Hormuz was reported struck by a projectile on Saturday, the latest escalation of tensions between the U.S. and Iran. The U.
Stock Valuations Should Worry Investors: Abby Joseph Cohen
Abby Joseph Cohen, professor at Columbia Business School, joins Lisa Mateo and Tom Keene on "Bloomberg Money." Lofty stock prices may be hiding risks